Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-19-006481
Filing Date
2019-04-29
Accepted
2019-04-29 11:14:53
Documents
43
Period of Report
2019-02-28

Document Format Files

Seq Description Document Type Size
1 10-Q s117541_10q.htm 10-Q 404948
2 EXHIBIT 31.1 s117541_ex31-1.htm EX-31.1 8106
3 EXHIBIT 32.1 s117541_ex32-1.htm EX-32.1 4812
  Complete submission text file 0001615774-19-006481.txt   1929489

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE etni-20190228.xml EX-101.INS 257011
5 XBRL SCHEMA FILE etni-20190228.xsd EX-101.SCH 26203
6 XBRL CALCULATION FILE etni-20190228_cal.xml EX-101.CAL 34584
7 XBRL DEFINITION FILE etni-20190228_def.xml EX-101.DEF 84968
8 XBRL LABEL FILE etni-20190228_lab.xml EX-101.LAB 171477
9 XBRL PRESENTATION FILE etni-20190228_pre.xml EX-101.PRE 137947
Mailing Address 4700 SPRING STREET, ST 304 LA MESA CA 91942
Business Address 4700 SPRING STREET, ST 304 LA MESA CA 91942 (619) 330-2328
ENTEST GROUP, INC. (Filer) CIK: 0001449447 (see all company filings)

EIN.: 263431263 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 333-154989 | Film No.: 19774438
SIC: 2834 Pharmaceutical Preparations